Search research articles
Contact Us
Filters
Showing results (51-60 of 293) with videos related to
Page
of 30
Sort By:
F1000 Biology Reports
|
November 9, 2011
Gout, genetics and ABC transporters
Agnès Basseville, Susan E Bates
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
Epidermal growth factor receptor inhibitors: a moving target?
Susan E Bates, Tito Fojo
Cancer
|
November 14, 2018
Entinostat finds a path: A new study elucidates effects of the histone deacetylase inhibitor on the immune system
Ira Surolia, Susan E Bates
Nature Reviews. Clinical Oncology
|
February 24, 2016
Clinical trials: New drug for pancreatic cancer highlights the dual effect of regulatory approvals
Susan E Bates, Tito Fojo
Seminars in Oncology
|
March 13, 2021
Two decades of research toward the treatment of locally advanced and metastatic pancreatic cancer: Remarkable effort and limited gain
Celine Yeh, Susan E Bates
The Oncologist
|
April 24, 2025
Early phase trials: the perils of nonpublication
Adrian Sacher, Susan E Bates
The Oncologist
|
September 23, 2024
Clinical trial results: each patient's participation should count
William D Figg, Susan E Bates
The Oncologist
|
September 22, 2024
Highlights of ASCO 2024
Alfred I Neugut, Susan E Bates
JAMA Oncology
|
April 8, 2016
Romidepsin Therapy Over 5 Years in a Clinical Setting-Real-world Experience
Susan E Bates, Larisa J Geskin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Epigenetic modifiers: basic understanding and clinical development
Richard L Piekarz, Susan E Bates
Page
of 30
Search research articles
Search
Showing results (51-60 of 293) with videos related to
Sort By:
Page
of 30
F1000 Biology Reports
|
November 9, 2011
Gout, genetics and ABC transporters
Agnès Basseville, Susan E Bates
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2005
Epidermal growth factor receptor inhibitors: a moving target?
Susan E Bates, Tito Fojo
Cancer
|
November 14, 2018
Entinostat finds a path: A new study elucidates effects of the histone deacetylase inhibitor on the immune system
Ira Surolia, Susan E Bates
Nature Reviews. Clinical Oncology
|
February 24, 2016
Clinical trials: New drug for pancreatic cancer highlights the dual effect of regulatory approvals
Susan E Bates, Tito Fojo
Seminars in Oncology
|
March 13, 2021
Two decades of research toward the treatment of locally advanced and metastatic pancreatic cancer: Remarkable effort and limited gain
Celine Yeh, Susan E Bates
The Oncologist
|
April 24, 2025
Early phase trials: the perils of nonpublication
Adrian Sacher, Susan E Bates
The Oncologist
|
September 23, 2024
Clinical trial results: each patient's participation should count
William D Figg, Susan E Bates
The Oncologist
|
September 22, 2024
Highlights of ASCO 2024
Alfred I Neugut, Susan E Bates
JAMA Oncology
|
April 8, 2016
Romidepsin Therapy Over 5 Years in a Clinical Setting-Real-world Experience
Susan E Bates, Larisa J Geskin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Epigenetic modifiers: basic understanding and clinical development
Richard L Piekarz, Susan E Bates
Page
of 30